(Q47652073)

4 February 2018

title

Circulating tumour cells in non-metastatic breast cancer: a prospective study (English)

1 reference

4 February 2018

non-metastatic breast cancer

main subject

1 reference

inferred from title

author

Anirban Bhattacharyya

4

1 reference

4 February 2018

author name string

Anthony Lucci

1

1 reference

4 February 2018

Carolyn S Hall

2

1 reference

4 February 2018

Ashutosh K Lodhi

3

1 reference

4 February 2018

Amber E Anderson

5

1 reference

4 February 2018

Lianchun Xiao

6

1 reference

4 February 2018

Isabelle Bedrosian

7

1 reference

4 February 2018

Henry M Kuerer

8

1 reference

4 February 2018

Savitri Krishnamurthy

9

1 reference

4 February 2018

publication date

6 June 2012

1 reference

4 February 2018

Lancet Oncology Commission

published in

1 reference

4 February 2018

volume

13

1 reference

4 February 2018

issue

7

1 reference

4 February 2018

page(s)

688-695

1 reference

4 February 2018

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Diagnostic plots to reveal functional form for covariates in multiplicative intensity models.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970209-7

7 January 2021

10.1016/S1470-2045(12)70209-7

Identifiers

DOI

1 reference

4 February 2018

release_dfmgu3bi3nakbm4i5mbveirbvu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dfmgu3bi3nakbm4i5mbveirbvu

24 November 2022

mapped directly with Wikidata item

1 reference

4 February 2018